Revelation Biosciences Inc (REVB)
2.06
-0.14
(-6.36%)
USD |
NASDAQ |
May 10, 16:00
2.00
-0.06
(-2.91%)
After-Hours: 20:00
Revelation Biosciences Shareholders Equity (Quarterly): 6.648M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.648M |
| September 30, 2023 | 8.818M |
| June 30, 2023 | 11.41M |
| March 31, 2023 | 10.02M |
| December 31, 2022 | 1.052M |
| Date | Value |
|---|---|
| September 30, 2022 | 2.228M |
| June 30, 2022 | -1.843M |
| March 31, 2022 | -0.0985M |
| December 31, 2021 | -0.0995M |
| September 30, 2021 | 3.655M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.843M
Minimum
Jun 2022
11.41M
Maximum
Jun 2023
4.179M
Average
2.941M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cardiff Oncology Inc | 60.89M |
| Ocular Therapeutix Inc | 407.98M |
| Ocugen Inc | 40.56M |
| Cue Biopharma Inc | 37.08M |
| Solid Biosciences Inc | 126.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.21M |
| Total Liabilities (Quarterly) | 5.565M |